Efforts to suppress spending on life-saving drugs are working—while development of new drugs is stagnating

By Jennifer Popik, JD, Robert Powell Center for Medical EthicsNew analysis details a disappointing explanation for recent decreases in Medicare spending growth – a paucity of new life-saving and health-preserving drugs...MORE

Even bigoted study finds high-cost drugs worth it

Burke J. Balch, J.D., director of the National Right to Life Committee’s Powell Center for Medical Ethics These days, as for some time past, much outrage is directed at pricey drugs, and both the government and insurance companies... MORE

In California access to top docs and hospitals dwindles under Obamacare

Jennifer Popik, JD, Robert Powell Center for Medical Ethics Californians with health insurance obtained through the Obamacare exchange are continuing to find themselves being turned away when they seek out many top health care specialists and hospitals, according...MORE